Orpenem 200 Tablet contains Faropenem 200 mg, a broad-spectrum oral beta-lactam antibiotic belonging to the penem subclass. It exhibits potent bactericidal activity by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins, leading to cell lysis and death. Orpenem 200 is indicated for the treatment of various bacterial infections caused by susceptible Gram-positive and Gram-negative pathogens, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and intra-abdominal infections. The drug demonstrates efficacy against common pathogens such as Streptococcus pneumoniae, Haemophilus influenzae, Escherichia coli, and Klebsiella species. Faropenem’s oral bioavailability allows convenient outpatient therapy, with a favorable safety profile and minimal adverse effects. It is generally well-tolerated, with occasional reports of gastrointestinal disturbances such as nausea, diarrhea, and abdominal discomfort. Caution is advised in patients with a history of beta-lactam hypersensitivity. Dosage should be adjusted based on infection severity, renal function, and patient response. Resistance development remains a concern; therefore, susceptibility testing is recommended prior to therapy initiation. Orpenem 200 Tablet should be used as directed by a healthcare professional to ensure optimal therapeutic outcomes and minimize resistance risk.